Hydrochloric Acid

Hydrochloric Acid

SCHEMBL8940929

CC(C)(C)NCc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1.Cl

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 3/20 0.52
CA2 known ✓ P00918 2/20 0.48
SCN2A known ✓ Q99250 2/20 0.48
GSR P00390 2/20 0.62
ALDH1A1 P00352 9/20 0.52
TSHR P16473 3/20 0.52
LMNA P02545 2/20 0.52
MAPK1 P28482 3/20 0.50
MEN1 O00255 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
BLM P54132 2/20 0.50
KMT2A Q03164 2/20 0.50
ATM Q13315 2/20 0.50
HIF1A Q16665 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
ALOX15 P16050 2/20 0.50
GMNN O75496 1/20 0.50
GABBR2 O75899 1/20 0.50
TP53 P04637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9124297 0.98 GSR (0.61) GSRALDH1A1TSHRGAALMNA
SCHEMBL9416987 0.87 CYP1A2 (0.52) GSRALDH1A1TSHRGAALMNA
Hydrochloric Acid SCHEMBL8843405 0.82 GSR (0.64) GSRALDH1A1TSHRGAALMNA
SCHEMBL28292868 0.82 GSR (0.65) GSRALDH1A1TSHRGAALMNA
SCHEMBL19937119 0.82 GSR (0.76) GSRALDH1A1TSHRGAALMNA
SCHEMBL7511206 0.80 GSR (0.62) GSRALDH1A1TSHRGAALMNA
SCHEMBL5791663 0.80 GSR (0.62) GSRALDH1A1TSHRGAALMNA
SCHEMBL17550780 0.79 GSR (0.53) GSRALDH1A1TSHRGAALMNA
Hydrochloric Acid SCHEMBL8843543 0.79 GSR (0.70) GSRALDH1A1TSHRGAALMNA
SCHEMBL11775795 0.78 GSR (0.61) GSRALDH1A1TSHRGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5552439-A AMINOPHENOL DERIVATIVES ELI LILLY AND COMPANY (US) 1996-09-03 US disclosed
EP-0680755-A1 Method for treating inflammation, ischemia-induced cell damage and muscular dystrophy ELI LILLY AND COMPANY (US) 1995-11-08 EP disclosed
EP-0474403-B1 Method of treating inflammatory bowel disease LILLY CO ELI (US) 1995-05-10 EP disclosed
US-5393786-A Administering certain phenolic compounds ELI LILLY AND COMPANY (US) 1995-02-28 US disclosed
US-5281623-A Administering amino substituted phenolic derivatives as antiinflammatory or antiarthritic agents ELI LILLY AND COMPANY (US) 1994-01-25 US disclosed
US-5280046-A Using an amide containing phenol compound THE UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1994-01-18 US disclosed
EP-0500336-A1 Composition containing certain phenol and benzamide for the treatment of type I diabetes UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-08-26 EP disclosed
EP-0476846-A2 Method for treating imflammation, ischemia-induced cell damage and muscular dystrophy ELI LILLY AND COMPANY (US) 1992-03-25 EP disclosed
EP-0474403-A1 Method of treating inflammatory bowel disease ELI LILLY AND COMPANY (US) 1992-03-11 EP disclosed